Friday, 21 June 2024

ERJ pick of the week

This randomised controlled trial did not demonstrate any clinical benefit of adjuvant prednisone in people with cystic fibrosis not responding to antibiotic treatment for a pulmonary exacerbation. 

Read the article | Submit to the European Respiratory Journal

No comments:

Post a Comment